OpenEvidence Confirms It Has Raised An Additional $250 Million At A $15 Billion Valuation

ForbesPublished 25 days ago

OpenEvidence, an AI-powered clinical decision support tool, has secured an additional $250 million in funding, reaching a valuation of $15 billion. This investment underscores the growing financial interest in AI applications within healthcare.

OpenEvidence Confirms It Has Raised An Additional $250 Million At A $15 Billion Valuation

More on this story

More in Healthcare

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

UK government sets out $800 million for AI security funding